Raymond James Financial Services Advisors, Inc. Cytosorbents Corp Transaction History
Raymond James Financial Services Advisors, Inc.
- $69.1 Billion
- Q2 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Cytosorbents Corp stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 60,591 shares of CTSO stock, worth $81,797. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,591
Previous 60,591
-0.0%
Holding current value
$81,797
Previous $57,000
26.32%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CTSO
# of Institutions
55Shares Held
16.9MCall Options Held
10.1KPut Options Held
500-
Avenir Corp Washington, DC2.97MShares$4.01 Million0.21% of portfolio
-
Skylands Capital, LLC2.84MShares$3.84 Million0.3% of portfolio
-
Granahan Investment Management, LLC Waltham, MA2.66MShares$3.6 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$2.63 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.54MShares$2.07 Million0.0% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $58.8M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...